Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chim C Lang

Showing results (181-190 of 270) with videos related to

Pageof 27
Sort By:
Pharmacogenetics and Genomics|December 29, 2016
Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitorsSeyed H Mahmoudpour, Abirami Veluchamy, Moneeza K Siddiqui, et al.
European Journal of Heart Failure|March 17, 2021
Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaireAlice Ravera, Bernadet T Santema, Iziah E Sama, et al.
European Journal of Heart Failure|March 24, 2021
Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study)Pankaj Gupta, Adriaan A Voors, Prashanth Patel, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 1, 2020
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fractionJozine M Ter Maaten, Pieter Martens, Kevin Damman, et al.
European Journal of Heart Failure|April 30, 2016
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHFAdriaan A Voors, Stefan D Anker, John G Cleland, et al.
European Journal of Heart Failure|January 4, 2023
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndromeCamilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, et al.
European Journal of Heart Failure|March 8, 2019
Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failureJozine M Ter Maaten, Daan Kremer, Biniyam G Demissei, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 20, 2021
The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failurePaloma Pandhi, Koen W Streng, Stefan D Anker, et al.
European Journal of Heart Failure|December 5, 2019
The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approachMartijn F Hoes, Jasper Tromp, Wouter Ouwerkerk, et al.
Pageof 27

Showing results (181-190 of 270) with videos related to

Sort By:
Pageof 27
Pharmacogenetics and Genomics|December 29, 2016
Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitorsSeyed H Mahmoudpour, Abirami Veluchamy, Moneeza K Siddiqui, et al.
European Journal of Heart Failure|March 17, 2021
Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaireAlice Ravera, Bernadet T Santema, Iziah E Sama, et al.
European Journal of Heart Failure|March 24, 2021
Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study)Pankaj Gupta, Adriaan A Voors, Prashanth Patel, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 1, 2020
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fractionJozine M Ter Maaten, Pieter Martens, Kevin Damman, et al.
European Journal of Heart Failure|April 30, 2016
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHFAdriaan A Voors, Stefan D Anker, John G Cleland, et al.
European Journal of Heart Failure|January 4, 2023
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndromeCamilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, et al.
European Journal of Heart Failure|March 8, 2019
Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failureJozine M Ter Maaten, Daan Kremer, Biniyam G Demissei, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 20, 2021
The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failurePaloma Pandhi, Koen W Streng, Stefan D Anker, et al.
European Journal of Heart Failure|December 5, 2019
The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approachMartijn F Hoes, Jasper Tromp, Wouter Ouwerkerk, et al.
Pageof 27